Paperpal Prime Logo

Current Problems in Cancer : Impact Factor & More

eISSN: 1535-6345pISSN: 0147-0272

Key Metrics

CiteScore
5
H-Index
46
Impact Factor
< 5
SJR
Q3Oncology
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Problems in Cancer

Current Problems in Cancer Journal Specifications

Overview
Publisher MOSBY-ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1976
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Problems in Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Problems in Cancer

Clinicopathological profile and treatment outcomes of advanced/unresectable thymic malignancies from a tertiary care centre in India.
  • 7 Aug 2026
  • Current problems in cancer
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer.
  • 1 Aug 2026
  • Current problems in cancer
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
  • 1 Aug 2026
  • Current problems in cancer
Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.
  • 1 Aug 2026
  • Current problems in cancer
Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.
  • 1 Aug 2026
  • Current problems in cancer
When should the medical oncologist call the surgeon?
  • 1 Aug 2026
  • Current problems in cancer
Clinicopathological profile and treatment outcomes of advanced/unresectable thymic malignancies from a tertiary care centre in India.
  • 7 Aug 2026
  • Current problems in cancer
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer.
  • 1 Aug 2026
  • Current problems in cancer
Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.
  • 1 Aug 2026
  • Current problems in cancer
Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.
  • 1 Aug 2026
  • Current problems in cancer
Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.
  • 1 Aug 2026
  • Current problems in cancer
When should the medical oncologist call the surgeon?
  • 1 Aug 2026
  • Current problems in cancer

FAQs on Current Problems in Cancer